JPWO2020005974A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020005974A5
JPWO2020005974A5 JP2020572414A JP2020572414A JPWO2020005974A5 JP WO2020005974 A5 JPWO2020005974 A5 JP WO2020005974A5 JP 2020572414 A JP2020572414 A JP 2020572414A JP 2020572414 A JP2020572414 A JP 2020572414A JP WO2020005974 A5 JPWO2020005974 A5 JP WO2020005974A5
Authority
JP
Japan
Prior art keywords
composition
vector
nucleic acid
single nucleic
clrn1
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020572414A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021529519A (ja
JP2021529519A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/039030 external-priority patent/WO2020005974A1/en
Publication of JP2021529519A publication Critical patent/JP2021529519A/ja
Publication of JPWO2020005974A5 publication Critical patent/JPWO2020005974A5/ja
Publication of JP2021529519A5 publication Critical patent/JP2021529519A5/ja
Priority to JP2023135405A priority Critical patent/JP2023153320A/ja
Priority to JP2025112689A priority patent/JP2025156349A/ja
Pending legal-status Critical Current

Links

JP2020572414A 2018-06-25 2019-06-25 Clrn1に関連する聴力喪失及び/または視力喪失を治療する方法 Pending JP2021529519A (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2023135405A JP2023153320A (ja) 2018-06-25 2023-08-23 Clrn1に関連する聴力喪失及び/または視力喪失を治療する方法
JP2025112689A JP2025156349A (ja) 2018-06-25 2025-07-03 Clrn1に関連する聴力喪失及び/または視力喪失を治療する方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862689660P 2018-06-25 2018-06-25
US62/689,660 2018-06-25
PCT/US2019/039030 WO2020005974A1 (en) 2018-06-25 2019-06-25 Methods of treating clrn1-associated hearing loss and/or vision loss

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023135405A Division JP2023153320A (ja) 2018-06-25 2023-08-23 Clrn1に関連する聴力喪失及び/または視力喪失を治療する方法

Publications (3)

Publication Number Publication Date
JP2021529519A JP2021529519A (ja) 2021-11-04
JPWO2020005974A5 true JPWO2020005974A5 (https=) 2022-06-24
JP2021529519A5 JP2021529519A5 (https=) 2022-06-24

Family

ID=68985009

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2020572414A Pending JP2021529519A (ja) 2018-06-25 2019-06-25 Clrn1に関連する聴力喪失及び/または視力喪失を治療する方法
JP2023135405A Pending JP2023153320A (ja) 2018-06-25 2023-08-23 Clrn1に関連する聴力喪失及び/または視力喪失を治療する方法
JP2025112689A Pending JP2025156349A (ja) 2018-06-25 2025-07-03 Clrn1に関連する聴力喪失及び/または視力喪失を治療する方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2023135405A Pending JP2023153320A (ja) 2018-06-25 2023-08-23 Clrn1に関連する聴力喪失及び/または視力喪失を治療する方法
JP2025112689A Pending JP2025156349A (ja) 2018-06-25 2025-07-03 Clrn1に関連する聴力喪失及び/または視力喪失を治療する方法

Country Status (14)

Country Link
US (1) US20210277417A1 (https=)
EP (1) EP3824090A4 (https=)
JP (3) JP2021529519A (https=)
KR (1) KR20210057720A (https=)
CN (1) CN112639107B (https=)
AU (2) AU2019294603B2 (https=)
BR (1) BR112020026606A2 (https=)
CA (1) CA3104330A1 (https=)
CL (1) CL2020003346A1 (https=)
EA (1) EA202190114A1 (https=)
IL (1) IL279551A (https=)
MX (1) MX2020013628A (https=)
SG (1) SG11202012710WA (https=)
WO (1) WO2020005974A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230340038A1 (en) * 2020-09-14 2023-10-26 President And Fellows Of Harvard College Recombinant adeno associated virus (raav) encoding gjb2 and uses thereof
MX2023007800A (es) * 2020-12-29 2023-07-11 Akouos Inc Composiciones y metodos para tratar la perdida de audicion y/o la perdida de vision asociada a clrn1.
CA3233522A1 (en) * 2021-09-30 2023-04-06 Katherine Diane GRIBBLE Gene therapy delivery compositions and methods for treating hearing loss

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8980952B2 (en) * 2002-03-20 2015-03-17 University Of Maryland, Baltimore Methods for treating brain swelling with a compound that blocks a non-selective cation channel
KR20080016786A (ko) * 2005-02-03 2008-02-22 주식회사 바이오텍 아이 당뇨병 치료용 조성물 및 당뇨병 치료 방법
JP2009511014A (ja) * 2005-10-05 2009-03-19 ベイヒル セラピューティクス インコーポレーティッド 自己免疫疾患の処置のための組成物および方法
US20090215178A1 (en) * 2008-02-22 2009-08-27 Zequn Tang Methods to enhance the stability and homogeneity of transgene expression in clonal cell lines
WO2011061937A1 (en) * 2009-11-19 2011-05-26 Immuno Tec Laboratory Co., Ltd. Methods for producing antibody-producing cells that produce desired polypeptides
RU2658490C2 (ru) * 2012-03-27 2018-06-21 Кьюрвак Аг Искусственные молекулы нуклеиновых кислот для улучшенной экспрессии белков или пептидов
CN102978284A (zh) * 2012-11-19 2013-03-20 金子兵 一种筛查各类眼科遗传性疾病的基因芯片及其制备和使用方法
ES2697249T3 (es) * 2013-03-11 2019-01-22 Fond Telethon miR-204 y miR-211 y usos de los mismos
CA2909733C (en) * 2013-04-18 2023-10-17 Fondazione Telethon Effective delivery of large genes by dual aav vectors
WO2016073900A1 (en) * 2014-11-06 2016-05-12 Case Western Reserve University Compositions and methods of treating usher syndrome iii
CN107921118B (zh) * 2015-06-12 2022-11-08 葛兰素史密丝克莱恩生物有限公司 腺病毒多核苷酸和多肽
SG11201804814YA (en) * 2015-12-11 2018-07-30 Massachusetts Eye & Ear Infirmary Materials and methods for delivering nucleic acids to cochlear and vestibular cells
JP2019530737A (ja) * 2016-08-23 2019-10-24 アコーオス インコーポレイテッド ヒト対象において非加齢性聴力障害を治療するための組成物および方法

Similar Documents

Publication Publication Date Title
AU2010311376B2 (en) Cardiac-specific nucleic acid regulatory elements and methods and use thereof
JP2021513863A5 (https=)
US9217020B2 (en) Constructs for enhancement of gene expression in muscle
JP2021530227A5 (https=)
AU2018352855B2 (en) Adeno-associated virus compositions for restoring HBB gene function and methods of use thereof
AU2015296861A1 (en) High isomerohydrolase activity mutants of mammalian RPE65
JPWO2019165292A5 (https=)
JP2021529519A5 (https=)
JP2020535804A5 (https=)
IL292605B2 (en) CRISPR and AAV strategies for treating childhood X-linked retinoschisis
TW202421787A (zh) 保護心臟之心臟病療法
KR20250102136A (ko) 중추 신경계에서의 유전자 발현을 위한 핵산 조절 요소 및 사용 방법
US11096955B2 (en) Synthetic promoters and uses thereof
JPWO2020005974A5 (https=)
Souza et al. Novel cloning method for recombinant adenovirus construction in Escherichia coli
JPWO2020014625A5 (https=)
CN112041437A (zh) 用于恢复f8基因功能的腺相关病毒组合物和其使用方法
JP2017511145A (ja) 筋強直性ジストロフィーの処置
US7368553B2 (en) Alternatively spliced nucleic acid molecules
JPWO2020038473A5 (https=)
EP4635519A1 (en) Method for gene regulation and use thereof
Wang et al. Molecular cloning, and characterization and expression of dihydrolipoamide acetyltransferase component of murine pyruvate dehydrogenase complex in bile duct cancer cells
JPH10146191A (ja) ウィルソン病治療用の組換えアデノウイルスベクター
WO2025122739A1 (en) Compositions and methods for treating a heart disease
AU2014240247B2 (en) Cardiac-specific nucleic acid regulatory elements and methods and use thereof